Literature DB >> 6147589

Ivermectin in onchocerciasis.

J P Coulaud, M Lariviere, M A Aziz, M C Gervais, P Gaxotte, A M Deluol, J Cenac.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147589     DOI： 10.1016/s0140-6736(84)92608-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.

Authors:  A Van der Lelij; A Rothova; N Klaassen-Broekema; W R Wilson; R F Barbe; J S Stilma
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

2.  Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

Authors:  H S Newland; A T White; B M Greene; S A D'Anna; E Keyvan-Larijani; M A Aziz; P N Williams; H R Taylor
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

3.  Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.

Authors:  K Y Dadzie; A C Bird; K Awadzi; H Schulz-Key; H M Gilles; M A Aziz
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

4.  Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice.

Authors:  Maha M A Basyoni; Abdel-Aleem A El-Sabaa
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.